A DNA Methylation-Based Panel for the Prognosis and Dagnosis of Patients With Breast Cancer and Its Mechanisms

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

(2019) Robert M. Samstein et al.   NATURE GENETICS

Systemic treatment and radiotherapy, breast cancer subtypes, and survival after long-term clinical follow-up

(2019) Sherry X. Yang et al.   BREAST CANCER RESEARCH AND TREATMENT

A seven‐DNA methylation signature as a novel prognostic biomarker in breast cancer

(2019) Chuntao Tao et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

A prognostic eight‐gene expression signature for patients with breast cancer receiving adjuvant chemotherapy

(2019) Qiuxia Cui et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Incidence and survival outcomes of early male breast cancer: a population-based comparison with early female breast cancer

(2019) Yan Wang et al.   Annals of Translational Medicine

A four-mRNA model to improve the prediction of breast cancer prognosis

(2019) Lingyu Qi et al.   GENE

Endocrine-based therapy versus chemotherapy in advanced breast cancer

(2019) Marie Robert et al.   LANCET ONCOLOGY

Neoadjuvant systemic treatment for breast cancer in Italy: The Italian Society of Surgical Oncology (SICO) Breast Oncoteam survey

(2018) E. Vicini et al.   EJSO

The Immune Landscape of Cancer

(2018) Vésteinn Thorsson et al.   IMMUNITY

Consistent inverse correlation between DNA methylation of the first intron and gene expression across tissues and species

(2018) Dafni Anastasiadi et al.   Epigenetics & Chromatin

Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer

(2018) Xiangchun Li et al.   JAMA Oncology

Maftools: efficient and comprehensive analysis of somatic variants in cancer

(2018) Anand Mayakonda et al.   GENOME RESEARCH

Integrated proteotranscriptomics of breast cancer reveals globally increased protein-mRNA concordance associated with subtypes and survival

(2018) Wei Tang et al.   Genome Medicine

Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)

(2017) M.J. Duffy et al.   EUROPEAN JOURNAL OF CANCER

DNA methylation–based immune response signature improves patient diagnosis in multiple cancers

(2017) Jana Jeschke et al.   JOURNAL OF CLINICAL INVESTIGATION

Breast cancer

(2017) Nadia Harbeck et al.   LANCET

Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy

(2017) Teresa Davoli et al.   SCIENCE

Incidence and Mortality and Epidemiology of Breast Cancer in the World

(2016) Mahshid Ghoncheh et al.   Asian Pacific Journal of Cancer Prevention

American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline

(2016) Carolyn D. Runowicz et al.   JOURNAL OF CLINICAL ONCOLOGY

Breast cancer incidence: Decreasing trend in large tumours in women aged 50–74

(2016) Florence Molinié et al.   JOURNAL OF MEDICAL SCREENING

DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients

(2016) Andrea Mathe et al.   Scientific Reports

Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity

(2015) Michael S. Rooney et al.   CELL

Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer

(2015) Giovanni Ciriello et al.   CELL

c060: Extended Inference with Lasso and Elastic-Net Regularized Cox and Generalized Linear Models

(2015) Martin Sill et al.   Journal of Statistical Software

Pathway-Centric Integrative Analysis Identifies RRM2 as a Prognostic Marker in Breast Cancer Associated with Poor Survival and Tamoxifen Resistance

(2014) Nagireddy Putluri et al.   NEOPLASIA

GSVA: gene set variation analysis for microarray and RNA-Seq data

(2013) Sonja Hänzelmann et al.   BMC BIOINFORMATICS

Breast cancer statistics, 2013

(2013) Carol DeSantis et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer

(2013) Gabriela Bindea et al.   IMMUNITY

MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis

(2013) Atsushi Terunuma et al.   JOURNAL OF CLINICAL INVESTIGATION

Comprehensive molecular portraits of human breast tumours

(2012) Daniel C. Koboldt et al.   NATURE

MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma

(2012) Edmund A. Mroz et al.   ORAL ONCOLOGY

survcomp: an R/Bioconductor package for performance assessment and comparison of survival models

(2011) Markus S. Schröder et al.   BIOINFORMATICS

A signature of immune function genes associated with recurrence-free survival in breast cancer patients

(2011) Maria Libera Ascierto et al.   BREAST CANCER RESEARCH AND TREATMENT

A prognostic model for lymph node-negative breast cancer patients based on the integration of proliferation and immunity

(2011) Ensel Oh et al.   BREAST CANCER RESEARCH AND TREATMENT

Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer

(2011) Lucia De Monte et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Clinical significance of the 21-gene signature (Oncotype DX) in hormone receptor-positive early stage primary breast cancer in the Japanese population

(2010) Masakazu Toi et al.   CANCER

Molecular Anatomy of Breast Cancer Stroma and Its Prognostic Value in Estrogen Receptor–Positive and –Negative Cancers

(2010) Giampaolo Bianchini et al.   JOURNAL OF CLINICAL ONCOLOGY

A comparative study of survival models for breast cancer prognostication based on microarray data: does a single gene beat them all?

(2008) B. Haibe-Kains et al.   BIOINFORMATICS